森下仁丹の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/28 | 2,445 | 2,445 | 2,405 | 2,438 | -11 | -0.4% | 2,500 |
2023/09/27 | 2,447 | 2,449 | 2,403 | 2,449 | -1 | ±0% | 3,000 |
2023/09/26 | 2,479 | 2,480 | 2,450 | 2,450 | -28 | -1.1% | 7,600 |
2023/09/25 | 2,487 | 2,532 | 2,437 | 2,478 | -9 | -0.4% | 6,900 |
2023/09/22 | 2,451 | 2,509 | 2,449 | 2,487 | +21 | +0.9% | 8,400 |
2023/09/21 | 2,402 | 2,500 | 2,402 | 2,466 | +64 | +2.7% | 16,200 |
2023/09/20 | 2,448 | 2,448 | 2,401 | 2,402 | -46 | -1.9% | 5,900 |
2023/09/19 | 2,488 | 2,488 | 2,391 | 2,448 | +60 | +2.5% | 13,200 |
2023/09/15 | 2,380 | 2,443 | 2,370 | 2,388 | +17 | +0.7% | 24,400 |
2023/09/14 | 2,213 | 2,596 | 2,200 | 2,371 | +181 | +8.3% | 56,000 |
2023/09/13 | 2,197 | 2,234 | 2,190 | 2,190 | -1 | ±0% | 8,000 |
2023/09/12 | 2,160 | 2,201 | 2,160 | 2,191 | +31 | +1.4% | 6,400 |
2023/09/11 | 2,150 | 2,160 | 2,143 | 2,160 | +18 | +0.8% | 2,600 |
2023/09/08 | 2,142 | 2,155 | 2,138 | 2,142 | -3 | -0.1% | 3,700 |
2023/09/07 | 2,150 | 2,160 | 2,129 | 2,145 | +2 | +0.1% | 4,700 |
2023/09/06 | 2,178 | 2,178 | 2,122 | 2,143 | -10 | -0.5% | 8,700 |
2023/09/05 | 2,103 | 2,155 | 2,086 | 2,153 | +50 | +2.4% | 11,100 |
2023/09/04 | 2,087 | 2,117 | 2,087 | 2,103 | +17 | +0.8% | 5,100 |
2023/09/01 | 2,104 | 2,117 | 2,086 | 2,086 | -16 | -0.8% | 4,600 |
2023/08/31 | 2,067 | 2,108 | 2,055 | 2,102 | +62 | +3% | 10,200 |
2023/08/30 | 2,049 | 2,049 | 2,028 | 2,040 | +5 | +0.2% | 1,700 |
2023/08/29 | 2,055 | 2,055 | 2,020 | 2,035 | -20 | -1% | 4,400 |
2023/08/28 | 2,038 | 2,058 | 2,037 | 2,055 | +35 | +1.7% | 4,600 |
2023/08/25 | 2,028 | 2,028 | 2,013 | 2,020 | +2 | +0.1% | 2,000 |
2023/08/24 | 2,027 | 2,034 | 2,014 | 2,018 | +3 | +0.1% | 800 |
2023/08/23 | 2,027 | 2,027 | 2,014 | 2,015 | -4 | -0.2% | 1,500 |
2023/08/22 | 2,029 | 2,029 | 2,016 | 2,019 | -4 | -0.2% | 600 |
2023/08/21 | 2,014 | 2,023 | 2,012 | 2,023 | +7 | +0.3% | 2,000 |
2023/08/18 | 2,025 | 2,036 | 2,006 | 2,016 | -4 | -0.2% | 3,500 |
2023/08/17 | 2,034 | 2,034 | 2,013 | 2,020 | -21 | -1% | 4,600 |
2023/08/16 | 2,040 | 2,059 | 2,035 | 2,041 | +2 | +0.1% | 4,300 |
2023/08/15 | 2,053 | 2,060 | 2,038 | 2,039 | -13 | -0.6% | 5,500 |
2023/08/14 | 2,032 | 2,062 | 2,024 | 2,052 | +45 | +2.2% | 15,000 |
2023/08/10 | 2,070 | 2,070 | 2,005 | 2,007 | -43 | -2.1% | 15,200 |
2023/08/09 | 1,997 | 2,130 | 1,996 | 2,050 | +54 | +2.7% | 87,700 |
2023/08/08 | 2,002 | 2,002 | 1,996 | 1,996 | ±0 | ±0% | 600 |
2023/08/07 | 2,001 | 2,003 | 1,992 | 1,996 | -4 | -0.2% | 6,300 |
2023/08/04 | 1,987 | 2,000 | 1,987 | 2,000 | +6 | +0.3% | 800 |
2023/08/03 | 1,990 | 1,994 | 1,989 | 1,994 | +7 | +0.4% | 2,200 |
2023/08/02 | 1,987 | 1,996 | 1,987 | 1,987 | +1 | +0.1% | 600 |
2023/08/01 | 1,992 | 1,992 | 1,986 | 1,986 | -7 | -0.4% | 1,100 |
2023/07/31 | 1,994 | 2,003 | 1,985 | 1,993 | +6 | +0.3% | 2,000 |
2023/07/28 | 1,991 | 1,991 | 1,981 | 1,987 | -6 | -0.3% | 4,100 |
2023/07/27 | 2,003 | 2,003 | 1,992 | 1,993 | -5 | -0.3% | 1,700 |
2023/07/26 | 2,005 | 2,005 | 1,992 | 1,998 | +3 | +0.2% | 2,800 |
2023/07/25 | 2,009 | 2,009 | 1,995 | 1,995 | +1 | +0.1% | 1,100 |
2023/07/24 | 1,998 | 2,005 | 1,990 | 1,994 | -2 | -0.1% | 2,800 |
2023/07/21 | 1,987 | 1,996 | 1,986 | 1,996 | +9 | +0.5% | 1,100 |
2023/07/20 | 2,000 | 2,000 | 1,986 | 1,987 | -1 | -0.1% | 2,200 |
2023/07/19 | 1,994 | 1,999 | 1,986 | 1,988 | +2 | +0.1% | 3,100 |
451~
500
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
仁 丹 | 218,300円 | +0.3% | +9.2% | 2.98% | 12.43倍 | 0.74倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
NANO | 13,900円 | -30.6% | - | 0.00% | - | 3.60倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
坪田ラボ | 36,700円 | +3.2% | -21.7% | 0.00% | 62.74倍 | 5.93倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
OTS | 2,900円 | +33.3% | - | 0.00% | - | 13.43倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
ケイファーマ | 73,500円 | - | - | 0.00% | - | 3.78倍 |
|
慶応大学発ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム